Toralizumab
Toralizumab
Toralizumab (pronunciation: tor-uh-liz-yoo-mab) is a type of monoclonal antibody used in the treatment of certain medical conditions.
Etymology
The name "Toralizumab" is derived from the standard nomenclature for monoclonal antibodies. The suffix "-mab" indicates that it is a monoclonal antibody, while the infix "-lizu-" is used for immunomodulating monoclonal antibodies.
Usage
Toralizumab is used in the treatment of various diseases, including certain types of cancer and autoimmune diseases. It works by targeting specific proteins on the surface of cells, thereby helping the immune system to attack these cells.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Immunotherapy: A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.
- Autoimmune disease: A condition in which your immune system mistakenly attacks your body.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
See Also
External links
- Medical encyclopedia article on Toralizumab
- Wikipedia's article - Toralizumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski